Interferon alfa 2a in superficial bladder cancer prophylaxis: toleration and long-term follow-up. A phase I-II study. | Anticancer Res;11(6): 2167-70, 1991. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Interferon alfa 2a in superficial bladder cancer prophylaxis: toleration and long-term follow-up. A phase I-II study.

Bartoletti, R; Massimini, G; Criscuolo, D; Rizzo, M.

Affiliation

Bartoletti R; Department of Urology, University of Florence, Italy.

Anticancer Res ; 11(6): 2167-70, 1991.

Article in En | MEDLINE | ID: mdl-1776857

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Interferon-alpha Type of study: Observational_studies / Prognostic_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Anticancer Res Year: 1991 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Interferon-alpha Type of study: Observational_studies / Prognostic_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Anticancer Res Year: 1991 Document type: Article Affiliation country: